NOX2 as a target for drug development: Indications, possible complications, and progress

Antioxidants and Redox Signaling

Volumn 23, Issue 5, 2015, Pages 375-405

  Diebold, Becky A ^a   Smith, Susan M E ^b   Li, Yang ^a   Lambeth, J David ^a  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b KENNESAW STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMINOETHYLBENZENESULFONOFLUORIDE; APOCYNIN; ARSENOSOBENZENE; CELASTROL; EBSELEN; GLIOTOXIN; REACTIVE OXYGEN METABOLITE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE 2; SERINE PROTEINASE INHIBITOR; UNCLASSIFIED DRUG; CYBB PROTEIN, HUMAN; ENZYME INHIBITOR; MEMBRANE PROTEIN; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE;

ACUTE LUNG INJURY; ADULT RESPIRATORY DISTRESS SYNDROME; ALZHEIMER DISEASE; AMYOTROPHIC LATERAL SCLEROSIS; ASTHMA; AUTOIMMUNE DISEASE; BRAIN ISCHEMIA; CHRONIC OBSTRUCTIVE LUNG DISEASE; CYSTIC FIBROSIS; DENDRITIC CELL; DISEASE ASSOCIATION; ENZYME INHIBITION; HUMAN; HYPERTENSION; INFLAMMATORY DISEASE; MACROPHAGE; MICROGLIA; MUSCLE CELL; MUSCLE DISEASE; NEUTROPHIL; NONHUMAN; PARKINSON DISEASE; PHAGOCYTE; PRIORITY JOURNAL; PULMONARY HYPERTENSION; REVIEW; SCHIZOPHRENIA; TRAUMATIC BRAIN INJURY; VASCULAR DISEASE; ANIMAL; ANTAGONISTS AND INHIBITORS; CHEMISTRY; DRUG DEVELOPMENT; INFLAMMATION; METABOLISM;

ANIMALS; DRUG DISCOVERY; ENZYME INHIBITORS; HUMANS; INFLAMMATION; MEMBRANE GLYCOPROTEINS; NADPH OXIDASE;

EID: 84939428903     PISSN: 15230864     EISSN: 15577716     Source Type: Journal    
DOI: 10.1089/ars.2014.5862     Document Type: Review

References (342)

1. Global Surveillance, Prevention and Control of Chronic Respiratory Diseases: A Comprehensive Approach, edited by WHO. Geneva: World Health Organization Press, 2007.
2. Dementia: A Public Health Priority. Geneva: World Health Organization, 2012.
3. Abdelrahman M, Mazzon E, Bauer M, Bauer I, Delbosc S, Cristol J-P, Patel NSA, Cuzzocrea S, and Thiemermann C. Inhibitors of NADPH oxidase reduce the organ injury in hemorrhagic shock. Shock 23: 107-114, 2005.
4. Abo A, Pick E, Hall A, Totty N, Teahan CG, and Segal AW. Activation of the NADPH oxidase involves the small GTP-binding protein p21rac1. Nature 353: 668-670, 1991.
5. Aguirre J and Lambeth JD. Nox enzymes from fungus to fly to fish and what they tell us about Nox function in mammals. Free Radic Biol Med 49: 1342-1353, 2010.
6. Akasaki T, Ohya Y, Kuroda J, Eto K, Abe I, Sumimoto H, and Iida M. Increased expression of gp91phox homologues of NAD(P)H oxidase in the aortic media during chronic hypertension: Involvement of the renin-angiotensin system. Hypertens Res 29: 813-820, 2006.
7. Akki A, Zhang M, Murdoch C, Brewer A, and Shah AM. NADPH oxidase signaling and cardiac myocyte function. J Mol Cell Cardiol 47: 15-22, 2009.
8. Aldieri E, Riganti C, Polimeni M, Gazzano E, Lussiana C, Campia I, and Ghigo D. Classical inhibitors of NOX NAD(P)H oxidases are not specific. Curr Drug Metab 9: 686-696, 2008.
9. Ambasta RK, Kumar P, Griendling KK, Schmidt HH, Busse R, and Brandes RP. Direct interaction of the novel Nox proteins with p22phox is required for the formation of a functionally active NADPH oxidase. J Biol Chem 279: 45935-45941, 2004.
10. Ansari MA and Scheff SW. NADPH-oxidase activation and cognition in Alzheimer disease progression. Free Radic Biol Med 51: 171-178, 2011.
11. Aracena-Parks P, Goonasekera SA, Gilman CP, Dirksen RT, Hidalgo C, and Hamilton SL. Identification of cysteines involved in S-nitrosylation, S-glutathionylation, and oxidation to disulfides in ryanodine receptor type 1. J Biol Chem 281: 40354-40368, 2006.
12. Bae YS, Kang SW, Seo MS, Baines IC, Tekle E, Chock PB, and Rhee SG. Epidermal growth factor (EGF)-induced generation of hydrogen peroxide. Role in EGF receptormediated tyrosine phosphorylation. J Biol Chem 272: 217-221, 1997.
13. Bae YS, Lee JH, Choi SH, Kim S, Almazan F, Witztum JL, and Miller YI. Macrophages generate reactive oxygen species in response to minimally oxidized low-density lipoprotein: Toll-like receptor 4-and spleen tyrosine kinase-dependent activation of NADPH oxidase 2. Circ Res 104: 210-218, 21p following 218, 2009.
14. Banerjee ER and Henderson WR, Jr. Characterization of lung stem cell niches in a mouse model of bleomycininduced fibrosis. Stem Cell Res Ther 3: 21, 2012.
15. Banerjee ER and Henderson WR, Jr. Role of T cells in a gp91phox knockout murine model of acute allergic asthma. Allergy Asthma Clin Immunol 9: 6, 2013.
16. Barbieri SS, Cavalca V, Eligini S, Brambilla M, Caiani A, Tremoli E, and Colli S. Apocynin prevents cyclooxygenase 2 expression in human monocytes through NADPH oxidase and glutathione redox-dependent mechanisms. Free Radic Biol Med 37: 156-165, 2004.
17. Bedard K and Krause KH. The NOX family of ROSgenerating NADPH oxidases: Physiology and pathophysiology. Physiol Rev 87: 245-313, 2007.
18. Beghi E, Chio A, Couratier P, Esteban J, Hardiman O, Logroscino G, Millul A, Mitchell D, Preux PM, Pupillo E, Stevic Z, Swingler R, Traynor BJ, Van den Berg LH, Veldink JH, and Zoccolella S. The epidemiology and treatment of ALS: Focus on the heterogeneity of the disease and critical appraisal of therapeutic trials. Amyotroph Lateral Scler 12: 1-10, 2011.
19. Behrens MM, Ali SS, Dao DN, Lucero J, Shekhtman G, Quick KL, and Dugan LL. Ketamine-induced loss of phenotype of fast-spiking interneurons is mediated by NADPH-oxidase. Science 318: 1645-1647, 2007.
20. Behrens MM, Ali SS, and Dugan LL. Interleukin-6 mediates the increase in NADPH-oxidase in the ketamine model of schizophrenia. J Neurosci 28: 13957-13966, 2008.
21. Berk M, Copolov D, Dean O, Lu K, Jeavons S, Schapkaitz I, Anderson-Hunt M, Judd F, Katz F, Katz P, Ording-Jespersen S, Little J, Conus P, Cuenod M, Do KQ, and Bush AI. N-acetyl cysteine as a glutathione precursor for schizophrenia-a double-blind, randomized, placebocontrolled trial. Biol Psychiatry 64: 361-368, 2008.
22. Bhandarkar SS, Jaconi M, Fried LE, Bonner MY, Lefkove B, Govindarajan B, Perry BN, Parhar R, Mackelfresh J, Sohn A, Stouffs M, Knaus U, Yancopoulos G, Reiss Y, Benest AV, Augustin HG, and Arbiser JL. Fulvene-5 potently inhibits NADPH oxidase 4 and blocks the growth of endothelial tumors in mice. J Clin Invest 119: 2359-2365, 2009.
23. Bianca VD, Dusi S, Bianchini E, Dal Pra I, and Rossi F. Beta-amyloid activates the O-2 forming NADPH oxidase in microglia, monocytes, and neutrophils. A possible inflammatory mechanism of neuronal damage in Alzheimer's disease. J Biol Chem 274: 15493-15499, 1999.
24. Bodas M, Tran I, and Vij N. Therapeutic strategies to correct proteostasis-imbalance in chronic obstructive lung diseases. Curr Mol Med 12: 807-814, 2012.
25. Bosco EE, Kumar S, Marchioni F, Biesiada J, Kordos M, Szczur K, Meller J, Seibel W, Mizrahi A, Pick E, Filippi MD, and Zheng Y. Rational design of small molecule inhibitors targeting the Rac GTPase-p67(phox) signaling axis in inflammation. Chem Biol 19: 228-242, 2012.
26. Bousquet J, Mantzouranis E, Cruz AA, Ait-Khaled N, Baena-Cagnani CE, Bleecker ER, Brightling CE, Burney P, Bush A, Busse WW, Casale TB, Chan-Yeung M, Chen R, Chowdhury B, Chung KF, Dahl R, Drazen JM, Fabbri LM, Holgate ST, Kauffmann F, Haahtela T, Khaltaev N, Kiley JP, Masjedi MR, Mohammad Y, O'Byrne P, Partridge MR, Rabe KF, Togias A, van Weel C, Wenzel S, Zhong N, and Zuberbier T. Uniform definition of asthma severity, control, and exacerbations: Document presented for the World Health Organization Consultation on severe asthma. J Allergy Clin Immunol 126: 926-938, 2010.
27. Brandes RP and Schroder K. Composition and functions of vascular nicotinamide adenine dinucleotide phosphate oxidases. Trends Cardiovasc Med 18: 15-19, 2008.
28. Brinkmann V, Reichard U, Goosmann C, Fauler B, Uhlemann Y, Weiss DS, Weinrauch Y, and Zychlinsky A. Neutrophil extracellular traps kill bacteria. Science 303: 1532-1535, 2004.
29. Briones AM, Tabet F, Callera GE, Montezano AC, Yogi A, He Y, Quinn MT, Salaices M, and Touyz RM. Differential regulation of Nox1, Nox2 and Nox4 in vascular smooth muscle cells from WKY and SHR. J Am Soc Hypertens 5: 137-153, 2011.
30. Brochet DX, Yang D, Cheng H, and Lederer WJ. Elementary calcium release events from the sarcoplasmic reticulum in the heart. Adv Exp Med Biol 740: 499-509, 2012.
31. Brown DI and Griendling KK. Nox proteins in signal transduction. Free Radic Biol Med 47: 1239-1253, 2009.
32. Brown JR, Goldblatt D, Buddle J, Morton L, and Thrasher AJ. Diminished production of anti-inflammatory mediators during neutrophil apoptosis and macrophage phagocytosis in chronic granulomatous disease (CGD). J Leukoc Biol 73: 591-599, 2003.
33. Bulut M, Savas HA, Altindag A, Virit O, and Dalkilic A. Beneficial effects of N-acetylcysteine in treatment resistant schizophrenia. World J Biol Psychiatry 10: 626-628, 2009.
34. Buttigieg J, Pan J, Yeger H, and Cutz E. NOX2 (gp91phox) is a predominant O2 sensor in a human airway chemoreceptor cell line: Biochemical, molecular, and electrophysiological evidence. Am J Physiol Lung Cell Mol Physiol 303: L598-L607, 2012.
35. Byrd AS, O'Brien XM, Johnson CM, Lavigne LM, and Reichner JS. An extracellular matrix-based mechanism of rapid neutrophil extracellular trap formation in response to Candida albicans. J Immunol 190: 4136-4148, 2013.
36. Cale CM, Morton L, and Goldblatt D. Cutaneous and other lupus-like symptoms in carriers of X-linked chronic granulomatous disease: Incidence and autoimmune serology. Clin Exp Immunol 148: 79-84, 2007.
37. Campuzano V, Segura-Puimedon M, Terrado V, Sanchez-Rodriguez C, Coustets M, Menacho-Marquez M, Nevado J, Bustelo XR, Francke U, and Perez-Jurado LA. Reduction of NADPH-oxidase activity ameliorates the cardiovascular phenotype in a mouse model of Williams-Beuren syndrome. PLoS Genet 8: E1002458, 2012.
38. Carnesecchi S, Deffert C, Pagano A, Garrido-Urbani S, Metrailler-Ruchonnet I, Schappi M, Donati Y, Matthay MA, Krause KH, and Barazzone Argiroffo C. NADPH oxidase-1 plays a crucial role in hyperoxia-induced acute lung injury in mice. Am J Respir Crit Care Med 180: 972-981, 2009.
39. Carnesecchi S, Pache JC, and Barazzone-Argiroffo C. NOX enzymes: Potential target for the treatment of acute lung injury. Cell Mol Life Sci 69: 2373-2385, 2012.
40. Cavarra E, Lucattelli M, Gambelli F, Bartalesi B, Fineschi S, Szarka A, Giannerini F, Martorana PA, and Lungarella G. Human SLPI inactivation after cigarette smoke exposure in a new in vivo model of pulmonary oxidative stress. Am J Physiol Lung Cell Mol Physiol 281: L412-L417, 2001.
41. Chen K, Nishi H, Travers R, Tsuboi N, Martinod K, Wagner DD, Stan R, Croce K, and Mayadas TN. Endocytosis of soluble immune complexes leads to their clearance by FcgammaRIIIB but induces neutrophil extracellular traps via FcgammaRIIA in vivo. Blood 120: 4421-4431, 2012.
42. Cheng G, Ritsick D, and Lambeth JD. Nox3 regulation by NOXO1, p47phox, and p67phox. J Biol Chem 279: 34250-34255, 2004.
43. Chiang CH, Chuang CH, and Liu SL. Apocynin attenuates ischemia-reperfusion lung injury in an isolated and perfused rat lung model. Transl Res 158: 17-29, 2011.
44. Chiang CL, Ledermann JA, Aitkens E, Benjamin E, Katz DR, and Chain BM. Oxidation of ovarian epithelial cancer cells by hypochlorous acid enhances immunogenicity and stimulates T cells that recognize autologous primary tumor. Clin Cancer Res 14: 4898-4907, 2008.
45. Choi BY, Jang BG, Kim JH, Lee BE, Sohn M, Song HK, and Suh SW. Prevention of traumatic brain injury-induced neuronal death by inhibition of NADPH oxidase activation. Brain Res 1481: 49-58, 2012.
46. Choi SH, Aid S, Kim HW, Jackson SH, and Bosetti F. Inhibition of NADPH oxidase promotes alternative and anti-inflammatory microglial activation during neuroinflammation. J Neurochem 120: 292-301, 2012.
47. Cifuentes-Pagano E, Csanyi G, and Pagano PJ. NADPH oxidase inhibitors: A decade of discovery from Nox2ds to HTS. Cell Mol Life Sci 69: 2315-2325, 2012.
48. Ciobica A, Padurariu M, Dobrin I, Stefanescu C, and Dobrin R. Oxidative stress in schizophrenia-focusing on the main markers. Psychiatr Danub 23: 237-245, 2011.
49. Clempus RE and Griendling KK. Reactive oxygen species signaling in vascular smooth muscle cells. Cardiovasc Res 71: 216-225, 2006.
50. Cooper JM, Petty RK, Hayes DJ, Morgan-Hughes JA, and Clark JB. Chronic administration of the oral hypoglycaemic agent diphenyleneiodonium to rats. An animal model of impaired oxidative phosphorylation (mitochondrial myopathy). Biochem Pharmacol 37: 687-694, 1988.
51. Cristovao AC, Guhathakurta S, Bok E, Je G, Yoo SD, Choi DH, and Kim YS. NADPH oxidase 1 mediates alpha-synucleinopathy in Parkinson's disease. J Neurosci 32: 14465-14477, 2012.
52. Cross AR. Inhibitors of the leukocyte superoxide generating oxidase: Mechanisms of action and methods for their elucidation. Free Radic Biol Med 8: 71-93, 1990.
53. Csanyi G, Cifuentes-Pagano E, Al Ghouleh I, Ranayhossaini DJ, Egana L, Lopes LR, Jackson HM, Kelley EE, and Pagano PJ. Nox2 B-loop peptide, Nox2ds, specifically inhibits the NADPH oxidase Nox2. Free Radic Biol Med 51: 1116-1125, 2011.
54. D'Addio SM and Prud'homme RK. Controlling drug nanoparticle formation by rapid precipitation. Adv Drug Deliv Rev 63: 417-426, 2011.
55. D'Alessandro A and Zolla L. The SODyssey: Superoxide dismutases from biochemistry, through proteomics, to oxidative stress, aging and nutraceuticals. Expert Rev Proteomics 8: 405-421, 2011.
56. Dahan I, Molshanski-Mor S, and Pick E. Inhibition of NADPH oxidase activation by peptides mapping within the dehydrogenase region of Nox2-A "peptide walking" study. J Leukoc Biol 91: 501-515, 2012.
57. Dahan I and Pick E. Strategies for identifying synthetic peptides to act as inhibitors of NADPH oxidases, or "all that you did and did not want to know about Nox inhibitory peptides". Cell Mol Life Sci 69: 2283-2305, 2012.
58. Dale DC, Boxer L, and Liles WC. The phagocytes: Neutrophils and monocytes. Blood 112: 935-945, 2008.
59. Deng HX, Hentati A, Tainer JA, Iqbal Z, Cayabyab A, Hung WY, Getzoff ED, Hu P, Herzfeldt B, Roos RP, et al. Amyotrophic lateral sclerosis and structural defects in Cu,Zn superoxide dismutase. Science 261: 1047-1051, 1993.
60. Diatchuk V, Lotan O, Koshkin V, Wikstroem P, and Pick E. Inhibition of NADPH oxidase activation by 4-(2-aminoethyl)-benzenesulfonyl fluoride and related compounds. J Biol Chem 272: 13292-13301, 1997.
61. Dickinson BC, Peltier J, Stone D, Schaffer DV, and Chang CJ. Nox2 redox signaling maintains essential cell populations in the brain. Nat Chem Biol 7: 106-112, 2011.
62. Dinauer MC, Pierce EA, Bruns GA, Curnutte JT, and Orkin SH. Human neutrophil cytochrome b light chain (p22-phox). Gene structure, chromosomal location, and mutations in cytochrome-negative autosomal recessive chronic granulomatous disease. J Clin Invest 86: 1729-1737, 1990.
63. Do KQ, Trabesinger AH, Kirsten-Kruger M, Lauer CJ, Dydak U, Hell D, Holsboer F, Boesiger P, and Cuenod M. Schizophrenia: Glutathione deficit in cerebrospinal fluid and prefrontal cortex in vivo. Eur J Neurosci 12: 3721-3728, 2000.
64. Dohi K, Ohtaki H, Nakamachi T, Yofu S, Satoh K, Miyamoto K, Song D, Tsunawaki S, Shioda S, and Aruga T. Gp91phox (NOX2) in classically activated microglia exacerbates traumatic brain injury. J Neuroinflamm 7: 41, 2010.
65. Donoso P, Sanchez G, Bull R, and Hidalgo C. Modulation of cardiac ryanodine receptor activity by ROS and RNS. Front Biosci 16: 553-567, 2011.
66. Dourron HM, Jacobson GM, Park JL, Liu J, Reddy DJ, Scheel ML, and Pagano PJ. Perivascular gene transfer of NADPH oxidase inhibitor suppresses angioplasty-induced neointimal proliferation of rat carotid artery. Am J Physiol Heart Circ Physiol 288: H946-H953, 2005.
67. Doussiere J, Bouzidi F, Poinas A, Gaillard J, and Vignais PV. Kinetic study of the activation of the neutrophil NADPH oxidase by arachidonic acid. Antagonistic effects of arachidonic acid and phenylarsine oxide. Biochemistry 38: 16394-16406, 1999.
68. Doussiere J, Gaillard J, and Vignais PV. The heme component of the neutrophil NADPH oxidase complex is a target for aryliodonium compounds. Biochemistry 38: 3694-3703, 1999.
69. Ekeowa UI, Gooptu B, Belorgey D, Hagglof P, Karlsson-Li S, Miranda E, Perez J, MacLeod I, Kroger H, Marciniak SJ, Crowther DC, and Lomas DA. Alpha1-antitrypsin deficiency, chronic obstructive pulmonary disease and the serpinopathies. Clin Sci (Lond) 116: 837-850, 2009.
70. El-Benna J, Dang PM, and Perianin A. Peptide-based inhibitors of the phagocyte NADPH oxidase. Biochem Pharmacol 80: 778-785, 2010.
71. El-Benna J, Dang PM, and Perianin A. Towards specific NADPH oxidase inhibition by small synthetic peptides. Cell Mol Life Sci 69: 2307-2314, 2012.
72. Eliades A, Matsuura S, and Ravid K. Oxidases and reactive oxygen species during hematopoiesis: A focus on megakaryocytes. J Cell Physiol 227: 3355-3362, 2012.
73. Engels F, Renirie BF, t Hart BA, Labadie RP, and Nijkamp FP. Effects of apocynin, a drug isolated from the roots of Picrorhiza kurroa, on arachidonic acid metabolism. FEBS Lett 305: 254-256, 1992.
74. Ermert D, Urban CF, Laube B, Goosmann C, Zychlinsky A, and Brinkmann V. Mouse neutrophil extracellular traps in microbial infections. J Innate Immun 1: 181-193, 2009.
75. Feng Y and Forgac M. Inhibition of vacuolar H( + )-ATPase by disulfide bond formation between cysteine 254 and cysteine 532 in subunit A. J Biol Chem 269: 13224-13230, 1994.
76. Fernandez-Boyanapalli RF, Frasch SC, McPhillips K, Vandivier RW, Harry BL, Riches DW, Henson PM, and Bratton DL. Impaired apoptotic cell clearance in CGD due to altered macrophage programming is reversed by phosphatidylserine-dependent production of IL-4. Blood 113: 2047-2055, 2009.
77. Fresquet F, Pourageaud F, Leblais V, Brandes RP, Savineau JP, Marthan R, and Muller B. Role of reactive oxygen species and gp91phox in endothelial dysfunction of pulmonary arteries induced by chronic hypoxia. Br J Pharmacol 148: 714-723, 2006.
78. Frey RS, Ushio-Fukai M, and Malik AB. NADPH oxidase-dependent signaling in endothelial cells: Role in physiology and pathophysiology. Antioxid Redox Signal 11: 791-810, 2009.
79. Fridovich I. Superoxide anion radical (O2-), superoxide dismutases, and related matters. J Biol Chem 272: 18515-18517, 1997.
80. Fridovich I. Fundamental aspects of reactive oxygen species, or what's the matter with oxygen? Ann N Y Acad Sci 893: 13-18, 1999.
81. Fu X, Kassim SY, Parks WC, and Heinecke JW. Hypochlorous acid oxygenates the cysteine switch domain of pro-matrilysin (MMP-7). A mechanism for matrix metalloproteinase activation and atherosclerotic plaque rupture by myeloperoxidase. J BiolChem276: 41279-41287, 2001.
82. Fuchs TA, Abed U, Goosmann C, Hurwitz R, Schulze I, Wahn V, Weinrauch Y, Brinkmann V, and Zychlinsky A. Novel cell death program leads to neutrophil extracellular traps. J Cell Biol 176: 231-241, 2007.
83. Gatley SJ and Martin JL. Some aspects of the pharmacology of diphenyleneiodonium, a bivalent iodine compound. Xenobiotica 9: 539-546, 1979.
84. Gatto GJ, Ao Z, Kearse MG, Zhou M, Morales CR, Daniels E, Bradley BT, Goserud MT, Goodman KB, Douglas SA, Harpel MR, and Johns DG. NADPH oxidase-dependent and-independent mechanisms of reported inhibitors of reactive oxygen generation. J Enzyme Inhibit Med Chem 28: 95-104, 2013.
85. Gelderman KA, Hultqvist M, Holmberg J, Olofsson P, and Holmdahl R. T cell surface redox levels determine T cell reactivity and arthritis susceptibility. Proc Natl Acad Sci USA 103: 12831-12836, 2006.
86. Gelderman KA, Hultqvist M, Olsson LM, Bauer K, Pizzolla A, Olofsson P, and Holmdahl R. Rheumatoid arthritis: The role of reactive oxygen species in disease development and therapeutic strategies. Antioxid Redox Signal 9: 1541-1567, 2007.
87. Gerber CE, Bruchelt G, Falk UB, Kimpfler A, Hauschild O, Kuci S, Bachi T, Niethammer D, and Schubert R. Reconstitution of bactericidal activity in chronic granulomatous disease cells by glucose-oxidase-containing liposomes. Blood 98: 3097-3105, 2001.
88. Gianni D, Taulet N, Zhang H, DerMardirossian C, Kister J, Martinez L, Roush WR, Brown SJ, Bokoch GM, and Rosen H. A novel and specific NADPH oxidase-1 (Nox1) small-molecule inhibitor blocks the formation of functional invadopodia in human colon cancer cells. ACS Chem Biol 5: 981-993, 2010.
89. Gorlach A, Brandes RP, Nguyen K, Amidi M, Dehghani F, and Busse R. A gp91phox containing NADPH oxidase selectively expressed in endothelial cells is a major source of oxygen radical generation in the arterial wall. Circ Res 87: 26-32, 2000.
90. Grasberger H and Refetoff S. Identification of the maturation factor for dual oxidase. Evolution of an eukaryotic operon equivalent. J Biol Chem 281: 18269-18272, 2006.
91. Hancock JT. The role of redox mechanisms in cell signalling. Mol Biotechnol 43: 162-166, 2009.
92. Hancock JT and Jones OT. The inhibition by diphenyleneiodonium and its analogues of superoxide generation by macrophages. Biochem J 242: 103-107, 1987.
93. Harper RW, Xu C, Eiserich JP, Chen Y, Kao CY, Thai P, Setiadi H, and Wu R. Differential regulation of dual NADPH oxidases/peroxidases, DUOX1 and DUOX2, by Th1 and Th2 cytokines in respiratory tract epithelium. FEBS Lett 579: 4911-4917, 2005.
94. Harraz MM, Marden JJ, Zhou W, Zhang Y, Williams A, Sharov VS, Nelson K, Luo M, Paulson H, Schoneich C, and Engelhardt JF. SOD1 mutations disrupt redoxsensitive Rac regulation of NADPH oxidase in a familial ALS model. J Clin Invest 118: 659-670, 2008.
95. Hayes E, Pohl K,McElvaney NG, and Reeves EP. The cystic fibrosis neutrophil: A specialized yet potentially defective cell. Arch Immunol Ther Exp (Warsz) 59: 97-112, 2011.
96. Heumuller S, Wind S, Barbosa-Sicard E, Schmidt HH, Busse R, Schroder K, and Brandes RP. Apocynin is not an inhibitor of vascular NADPH oxidases but an antioxidant. Hypertension 51: 211-217, 2008.
97. Heyworth PG, Cross AR, and Curnutte JT. Chronic granulomatous disease. Curr Opin Immunol 15: 578-584, 2003.
98. Hidalgo C, Sanchez G, Barrientos G, and Aracena-Parks P. A transverse tubule NADPH oxidase activity stimulates calcium release from isolated triads via ryanodine receptor type 1 S-glutathionylation. J BiolChem281: 26473-26482, 2006.
99. Ho WE, Cheng C, Peh HY, Xu F, Tannenbaum SR, Ong CN, and Wong WS. Anti-malarial drug artesunate ameliorates oxidative lung damage in experimental allergic asthma. Free Radic Biol Med 53: 498-507, 2012.
100. Holgate ST. Stratified approaches to the treatment of asthma. Br J Clin Pharmacol 76: 277-291, 2013.
101. Holmdahl R, Sareila O, Pizzolla A, Winter S, Hagert C, Jaakkola N, Kelkka T, Olsson LM, Wing K, and Backdahl L. Hydrogen peroxide as an immunological transmitter regulating autoreactive T cells. Antioxid Redox Signal 18: 1463-1474, 2013.
102. Hooper NM. Roles of proteolysis and lipid rafts in the processing of the amyloid precursor protein and prion protein. Biochem Soc Trans 33: 335-338, 2005.
103. Hsu MF, Raung SL, Tsao LT, Kuo SC, and Wang JP. Cellular localization of the inhibitory action of abruquinone A against respiratory burst in rat neutrophils. Br J Pharmacol 120: 917-925, 1997.
104. Hsu MF, Raung SL, Tsao LT, Lin CN, and Wang JP. Examination of the inhibitory effect of norathyriol in formylmethionyl-leucyl-phenylalanine-induced respiratory burst in rat neutrophils. Free Radic Biol Med 23: 1035-1045, 1997.
105. Huang J, Canadien V, Lam GY, Steinberg BE, Dinauer MC, Magalhaes MA, Glogauer M, Grinstein S, and Brumell JH. Activation of antibacterial autophagy by NADPH oxidases. Proc Natl Acad Sci USA 106: 6226-6231, 2009.
106. Hultqvist M and Holmdahl R. Ncf1 (p47phox) polymorphism determines oxidative burst and the severity of arthritis in rats and mice. Cell Immunol 233: 97-101, 2005.
107. Hultqvist M, Olofsson P, Holmberg J, Backstrom BT, Tordsson J, and Holmdahl R. Enhanced autoimmunity, arthritis, and encephalomyelitis in mice with a reduced oxidative burst due to a mutation in the Ncf1 gene. Proc Natl Acad Sci USA 101: 12646-12651, 2004.
108. Hultqvist M, Olsson LM, Gelderman KA, and Holmdahl R. The protective role of ROS in autoimmune disease. Trends Immunol 30: 201-208, 2009.
109. Hultqvist M, Sareila O, Vilhardt F, Norin U, Olsson LM, Olofsson P, Hellman U, and Holmdahl R. Positioning of a polymorphic quantitative trait nucleotide in the Ncf1 gene controlling oxidative burst response and arthritis severity in rats. Antioxid Redox Signal 14: 2373-2383, 2011.
110. Hunt JM and Tuder R. Alpha 1 anti-trypsin: One protein, many functions. Curr Mol Med 12: 827-835, 2012.
111. Ignarro LJ, Buga GM, Wood KS, Byrns RE, and Chaudhuri G. Endothelium-derived relaxing factor produced and released from artery and vein is nitric oxide. Proc Natl Acad Sci USA 84: 9265-9269, 1987.
112. Iiyama M, Kakihana K, Kurosu T, and Miura O. Reactive oxygen species generated by hematopoietic cytokines play roles in activation of receptor-mediated signaling and in cell cycle progression. Cell Signal 18: 174-182, 2006.
113. Ikai T, Akao Y, Nakagawa Y, Ohguchi K, Sakai Y, and Nozawa Y. Magnolol-induced apoptosis is mediated via the intrinsic pathway with release of AIF from mitochondria in U937 cells. Biol Pharm Bull 29: 2498-2501, 2006.
114. Imai Y, Kuba K, Neely GG, Yaghubian-Malhami R, Perkmann T, van Loo G, Ermolaeva M, Veldhuizen R, Leung YH, Wang H, Liu H, Sun Y, Pasparakis M, Kopf M, Mech C, Bavari S, Peiris JS, Slutsky AS, Akira S, Hultqvist M, Holmdahl R, Nicholls J, Jiang C, Binder CJ, and Penninger JM. Identification of oxidative stress and Toll-like receptor 4 signaling as a key pathway of acute lung injury. Cell 133: 235-249, 2008.
115. Irani K, Xia Y, Zweier JL, Sollott SJ, Der CJ, Fearon ER, Sundaresan M, Finkel T, and Goldschmidt-Clermont PJ. Mitogenic signaling mediated by oxidants in Rastransformed fibroblasts. Science 275: 1649-1652, 1997.
116. Jackman KA, Miller AA, De Silva TM, Crack PJ, Drummond GR, and Sobey CG. Reduction of cerebral infarct volume by apocynin requires pretreatment and is absent in Nox2-deficient mice. Br J Pharmacol 156: 680-688, 2009.
117. Jackson HM, Kawahara T, Nisimoto Y, Smith SM, and Lambeth JD. Nox4 B-loop creates an interface between the transmembrane and dehydrogenase domains. J Biol Chem 285: 10281-10290, 2010.
118. Jackson MJ. Control of reactive oxygen species production in contracting skeletal muscle. Antioxid Redox Signal 15: 2477-2486, 2011.
119. Jackson SH, Gallin JI, and Holland SM. The p47-phox mouse knock-out model of chronic granulomatous disease. J Exp Med 182: 751-758, 1996.
120. Jacob CO, Eisenstein M, Dinauer MC, Ming W, Liu Q, John S, Quismorio FP, Jr., Reiff A, Myones BL, Kaufman KM, McCurdy D, Harley JB, Silverman E, Kimberly RP, Vyse TJ, Gaffney PM, Moser KL, Klein-Gitelman M, Wagner-Weiner L, Langefeld CD, Armstrong DL, and Zidovetzki R. Lupus-associated causal mutation in neutrophil cytosolic factor 2 (NCF2) brings unique insights to the structure and function of NADPH oxidase. Proc Natl Acad Sci USA 109: E59-E67, 2012.
121. Jaquet V, Marcoux J, Forest E, Leidal KG, McCormick S, Westermaier Y, Perozzo R, Plastre O, Fioraso-Cartier L, Diebold B, Scapozza L, Nauseef WM, Fieschi F, Krause K-H, and Bedard K. NADPH oxidase (NOX) isoforms are inhibited by celastrol with a dual mode of action. Br J Pharmacol 164: 507-520, 2011.
122. Jaquet V, Scapozza L, Clark R, Krause KH, and Lambeth JD. Small molecule NOX inhibitors: ROS-generating NADPH oxidases as therapeutic targets. Antioxid Redox Signal 11: 2535-2552, 2009.
123. Johannesson M, Hultqvist M, and Holmdahl R. Genetics of autoimmune diseases: A multistep process. Curr Top Microbiol Immunol 305: 259-276, 2006.
124. Johansen KS. Nitroblue tetrazolium slide test. Use of the phorbol-myristate-acetate-stimulated NBT-reduction slide test for routine and prenatal detection of chronic granulomatous disease and diagnosis of heterozygous carriers. Acta Pathol Microbiol Immunol Scand C 91: 349-354, 1983.
125. Judkins CP, Diep H, Broughton BR, Mast AE, Hooker EU, Miller AA, Selemidis S, Dusting GJ, Sobey CG, and Drummond GR. Direct evidence of a role for Nox2 in superoxide production, reduced nitric oxide bioavailability, and early atherosclerotic plaque formation in ApoE-/-mice. Am J Physiol Heart Circ Physiol 298: H24-H32, 2009.
126. Jung O, Schreiber JG, Geiger H, Pedrazzini T, Busse R, and Brandes RP. gp91phox-containing NADPH oxidase mediates endothelial dysfunction in renovascular hypertension. Circulation 109: 1795-1801, 2004.
127. Kahle MP and Bix GJ. Successfully climbing the "STAIRs": Surmounting failed translation of experimental ischemic stroke treatments. Stroke Res Treat 2012: 374098, 2012.
128. Kahles T and Brandes RP. Which NADPH oxidase isoform is relevant for ischemic stroke? The case for Nox 2. Antioxid Redox Signal 18: 1400-1417, 2013.
129. Kahles T, Kohnen A, Heumueller S, Rappert A, Bechmann I, Liebner S, Wittko IM, Neumann-Haefelin T, Steinmetz H, Schroeder K, and Brandes RP. NADPH oxidase Nox1 contributes to ischemic injury in experimental stroke in mice. Neurobiol Dis 40: 185-192, 2010.
130. Kahles T, Luedike P, Endres M, Galla HJ, Steinmetz H, Busse R, Neumann-Haefelin T, and Brandes RP. NADPH oxidase plays a central role in blood-brain barrier damage in experimental stroke. Stroke 38: 3000-3006, 2007.
131. Kang EM, Choi U, Theobald N, Linton G, Long Priel DA, Kuhns D, and Malech HL. Retrovirus gene therapy for Xlinked chronic granulomatous disease can achieve stable long-term correction of oxidase activity in peripheral blood neutrophils. Blood 115: 783-791, 2010.
132. Kannaiyan R, Shanmugam MK, and Sethi G. Molecular targets of celastrol derived from Thunder of God Vine: Potential role in the treatment of inflammatory disorders and cancer. Cancer Lett 303: 9-20, 2011.
133. Kaplan MJ and Radic M. Neutrophil extracellular traps: Double-edged swords of innate immunity. J Immunol 189: 2689-2695, 2012.
134. Kawahara T, Ritsick D, Cheng G, and Lambeth JD. Point mutations in the proline-rich region of p22phox are dominant inhibitors of Nox1-and Nox2-dependent reactive oxygen generation. J Biol Chem 280: 31859-31869, 2005.
135. Khairallah RJ, Shi G, Sbrana F, Prosser BL, Borroto C, Mazaitis MJ, Hoffman EP, Mahurkar A, Sachs F, Sun Y, Chen YW, Raiteri R, Lederer WJ, Dorsey SG, and Ward CW. Microtubules underlie dysfunction in duchenne muscular dystrophy. Sci Signal 5: Ra56, 2012.
136. Kim D, You B, Jo EK, Han SK, Simon MI, and Lee SJ. NADPH oxidase 2-derived reactive oxygen species in spinal cord microglia contribute to peripheral nerve injury-induced neuropathic pain. Proc Natl Acad Sci USA 107: 14851-14856, 2010.
137. Kim JA, Neupane GP, Lee ES, Jeong BS, Park BC, and Thapa P. NADPH oxidase inhibitors: A patent review. Expert Opin Ther Pat 21: 1147-1158, 2011.
138. Kim SY, Moon KA, Jo HY, Jeong S, Seon SH, Jung E, Cho YS, Chun E, and Lee KY. Anti-inflammatory effects of apocynin, an inhibitor of NADPH oxidase, in airway inflammation. Immunol Cell Biol 90: 441-448, 2012.
139. Kishida KT, Hoeffer CA, Hu D, Pao M, Holland SM, and Klann E. Synaptic plasticity deficits and mild memory impairments in mouse models of chronic granulomatous disease. Mol Cell Biol 26: 5908-5920, 2006.
140. Kleinschnitz C, Grund H, Wingler K, Armitage ME, Jones E, Mittal M, Barit D, Schwarz T, Geis C, Kraft P, Barthel K, Schuhmann MK, Herrmann AM, Meuth SG, Stoll G, Meurer S, Schrewe A, Becker L, Gailus-Durner V, Fuchs H, Klopstock T, de Angelis MH, Jandeleit-Dahm K, Shah AM, Weissmann N, and Schmidt HH. Post-stroke inhibition of induced NADPH oxidase type 4 prevents oxidative stress and neurodegeneration. PLoS Biol 8: Pii: E1000479, 2010.
141. Kleniewska P, Piechota A, Skibska B, and Goraca A. The NADPH oxidase family and its inhibitors. Arch Immunol Ther Exp (Warsz) 60: 277-294, 2012.
142. Knaus UG, Heyworth PG, Evans T, Curnutte JT, and Bokoch GM. Regulation of phagocyte oxygen radical production by the GTP-binding protein Rac 2. Science 254: 1512-1515, 1991.
143. Koay MA, Christman JW, Segal BH, Venkatakrishnan A, Blackwell TR, Holland SM, and Blackwell TS. Impaired pulmonary NF-kappaB activation in response to lipopolysaccharide in NADPH oxidase-deficient mice. Infect Immun 69: 5991-5996, 2001.
144. Kobayashi SD, Voyich JM, Braughton KR, Whitney AR, NauseefWM, Malech HL, and DeLeo FR. Gene expression profiling provides insight into the pathophysiology of chronic granulomatous disease. J Immunol 172: 636-643, 2004.
145. Kotsias F, Hoffmann E, Amigorena S, and Savina A. Reactive oxygen species production in the phagosome: Impact on antigen presentation in dendritic cells. Antioxid Redox Signal 18: 714-729, 2013.
146. Kozel BA, Knutsen RH, Ye L, Ciliberto CH, Broekelmann TJ, and Mecham RP. Genetic modifiers of cardiovascular phenotype caused by elastin haploinsufficiency act by extrinsic noncomplementation. J Biol Chem 286: 44926-44936, 2011.
147. Krotz F, Sohn HY, Gloe T, Zahler S, Riexinger T, Schiele TM, Becker BF, Theisen K, Klauss V, and Pohl U. NAD(P)H oxidase-dependent platelet superoxide anion release increases platelet recruitment. Blood 100: 917-924, 2002.
148. Kuhns DB, Alvord WG, Heller T, Feld JJ, Pike KM, Marciano BE, Uzel G, DeRavin SS, Priel DA, Soule BP, Zarember KA, Malech HL, Holland SM, and Gallin JI. Residual NADPH oxidase and survival in chronic granulomatous disease. N Engl J Med 363: 2600-2610, 2010.
149. Kuiper JW, Sun C, Magalhaes MA, and Glogauer M. Rac regulates PtdInsP(3) signaling and the chemotactic compass through a redox-mediated feedback loop. Blood 118: 6164-6171, 2011.
150. Lagente V, Planquois JM, Leclerc O, Schmidlin F, and Bertrand CP. Oxidative stress is an important component of airway inflammation in mice exposed to cigarette smoke or lipopolysaccharide. Clin Exp Pharmacol Physiol 35: 601-605, 2008.
151. Laleu B, Gaggini F, Orchard M, Fioraso-Cartier L, Cagnon L, Houngninou-Molango S, Gradia A, Duboux G, Merlot C, Heitz F, Szyndralewiez C, and Page P. First in class, potent, and orally bioavailable NADPH oxidase isoform 4 (Nox4) inhibitors for the treatment of idiopathic pulmonary fibrosis. J Med Chem 53: 7715-7730, 2010.
152. Lam GY, Huang J, and Brumell JH. The many roles of NOX2 NADPH oxidase-derived ROS in immunity. Semin Immunopathol 32: 415-430, 2010.
153. Lambeth JD. NOX enzymes and the biology of reactive oxygen. Nat Rev Immunol 4: 181-189, 2004.
154. Lambeth JD. Nox enzymes, ROS, and chronic disease: An example of antagonistic pleiotropy. Free Radic Biol Med 43: 332-347, 2007.
155. Lambeth JD, Kawahara T, and Diebold B. Regulation of Nox and DUOX enzymatic activity and expression. Free Radic Biol Med 43: 319-331, 2007.
156. Lambeth JD, Krause KH, and Clark RA. NOX enzymes as novel targets for drug development. Semin Immunopathol 30: 339-363, 2008.
157. Landmesser U, Dikalov S, Price SR, McCann L, Fukai T, Holland SM, Mitch WE, and Harrison DG. Oxidation of tetrahydrobiopterin leads to uncoupling of endothelial cell nitric oxide synthase in hypertension. J Clin Invest 111: 1201-1209, 2003.
158. Lapouge K, Smith SJ,Walker PA, Gamblin SJ, Smerdon SJ, and Rittinger K. Structure of the TPR domain of p67phox in complex with Rac.GTP. Mol Cell 6: 899-907, 2000.
159. Lassegue B and Griendling KK. NADPH oxidases: Functions and pathologies in the vasculature. Arterioscler Thromb Vasc Biol 30: 653-661, 2010.
160. Lee CF, Qiao M, Schroder K, Zhao Q, and Asmis R. Nox4 is a novel inducible source of reactive oxygen species in monocytes and macrophages and mediates oxidized low density lipoprotein-induced macrophage death. Circ Res 106: 1489-1497, 2010.
161. Lee K, Won HY, Bae MA, Hong JH, and Hwang ES. Spontaneous and aging-dependent development of arthritis in NADPH oxidase 2 deficiency through altered differentiation of CD11b + and Th/Treg cells. Proc Natl Acad Sci USA 108: 9548-9553, 2011.
162. Lei M, Luo L, Ma SQ, Zhang Y, Wu XH, and Li L. [Behavioral and neurobiological abnormalities induced by social isolation as a useful animal model of schizophrenia]. Sheng Li Xue Bao 65: 101-108, 2013 [Article in Chinese].
163. Leto TL, Lomax KJ, Volpp BD, Nunoi H, Sechler JMG, Nauseef WM, Clark RA, Gallin JI, and Malech HL. Cloning of a 67-kD neutrophil oxidase factor with similarity to a noncatalytic region of p60c-src. Science 248: 727-730, 1990.
164. Li JM, Fan LM, Christie MR, and Shah AM. Acute tumor necrosis factor alpha signaling via NADPH oxidase in microvascular endothelial cells: Role of p47phox phosphorylation and binding to TRAF4. Mol Cell Biol 25: 2320-2330, 2005.
165. Li N, Li B, Brun T, Deffert-Delbouille C, Mahiout Z, Daali Y, Ma XJ, Krause KH, and Maechler P. NADPH oxidase NOX2 defines a new antagonistic role for reactive oxygen species and cAMP/PKA in the regulation of insulin secretion. Diabetes 61: 2842-2850, 2012.
166. Lincecum JM, Vieira FG, Wang MZ, Thompson K, De Zutter GS, Kidd J, Moreno A, Sanchez R, Carrion IJ, Levine BA, Al-Nakhala BM, Sullivan SM, Gill A, and Perrin S. From transcriptome analysis to therapeutic anti-CD40L treatment in the SOD1 model of amyotrophic lateral sclerosis. Nat Genet 42: 392-399, 2010.
167. Liu W, Chen Q, Liu J, and Liu KJ. Normobaric hyperoxia protects the blood brain barrier through inhibiting Nox2 containing NADPH oxidase in ischemic stroke. Med Gas Res 1: 22, 2011.
168. Liu Y, Hernandez-Ochoa EO, Randall WR, and Schneider MF. NOX2-dependent ROS is required for HDAC5 nuclear efflux and contributes to HDAC4 nuclear efflux during intense repetitive activity of fast skeletal muscle fibers. Am J Physiol Cell Physiol 303: C334-C347, 2012.
169. Lopes NH, Vasudevan SS, Gregg D, Selvakumar B, Pagano PJ, Kovacic H, and Goldschmidt-Clermont PJ. Racdependent monocyte chemoattractant protein-1 production is induced by nutrient deprivation. Circ Res 91: 798-805, 2002.
170. Lopez AD and Mathers CD. Measuring the global burden of disease and epidemiological transitions: 2002-2030. Ann Trop Med Parasitol 100: 481-499, 2006.
171. Lozano R, Naghavi M, Foreman K, Lim S, Shibuya K, Aboyans V, Abraham J, Adair T, Aggarwal R, Ahn SY, Alvarado M, Anderson HR, Anderson LM, Andrews KG, Atkinson C, Baddour LM, Barker-Collo S, Bartels DH, Bell ML, Benjamin EJ, Bennett D, Bhalla K, Bikbov B, Bin Abdulhak A, Birbeck G, Blyth F, Bolliger I, Boufous S, Bucello C, Burch M, Burney P, Carapetis J, Chen H, Chou D, Chugh SS, Coffeng LE, Colan SD, Colquhoun S, Colson KE, Condon J, Connor MD, Cooper LT, Corriere M, Cortinovis M, de Vaccaro KC, Couser W, Cowie BC, Criqui MH, Cross M, Dabhadkar KC, Dahodwala N, De Leo D, Degenhardt L, Delossantos A, Denenberg J, Des Jarlais DC, Dharmaratne SD, Dorsey ER, Driscoll T, Duber H, Ebel B, Erwin PJ, Espindola P, Ezzati M, Feigin V, Flaxman AD, Forouzanfar MH, Fowkes FG, Franklin R, Fransen M, Freeman MK, Gabriel SE, Gakidou E, Gaspari F, Gillum RF, Gonzalez-Medina D, Halasa YA, Haring D, Harrison JE, Havmoeller R, Hay RJ, Hoen B, Hotez PJ, Hoy D, Jacobsen KH, James SL, Jasrasaria R, Jayaraman S, Johns N, Karthikeyan G, Kassebaum N, Keren A, Khoo JP, Knowlton LM, Kobusingye O, Koranteng A, Krishnamurthi R, Lipnick M, Lipshultz SE, Ohno SL, Mabweijano J, MacIntyre MF, Mallinger L, March L, Marks GB, Marks R, Matsumori A, Matzopoulos R, Mayosi BM, McAnulty JH, McDermott MM, McGrath J, Mensah GA, Merriman TR, Michaud C, Miller M, Miller TR, Mock C, Mocumbi AO, Mokdad AA, Moran A, Mulholland K, Nair MN, Naldi L, Narayan KM, Nasseri K, Norman P, O'Donnell M, Omer SB, Ortblad K, Osborne R, Ozgediz D, Pahari B, Pandian JD, Rivero AP, Padilla RP, Perez-Ruiz F, Perico N, Phillips D, Pierce K, Pope CA, 3rd, Porrini E, Pourmalek F, Raju M, Ranganathan D, Rehm JT, Rein DB, Remuzzi G, Rivara FP, Roberts T, De Leon FR, Rosenfeld LC, Rushton L, Sacco RL, Salomon JA, Sampson U, Sanman E, Schwebel DC, Segui-Gomez M, Shepard DS, Singh D, Singleton J, Sliwa K, Smith E, Steer A, Taylor JA, Thomas B, Tleyjeh IM, Towbin JA, Truelsen T, Undurraga EA, Venketasubramanian N, Vijayakumar L, Vos T, Wagner GR, Wang M, Wang W, Watt K, Weinstock MA, Weintraub R, Wilkinson JD, Woolf AD, Wulf S, Yeh PH, Yip P, Zabetian A, Zheng ZJ, Lopez AD, and Murray CJ. Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: A systematic analysis for the Global Burden of Disease Study 2010. Lancet 380: 2095-2128, 2012.
172. Lu X, Wan S, Jiang J, Jiang X, Yang W, Yu P, Xu L, Zhang Z, Zhang G, Shan L, and Wang Y. Synthesis and biological evaluations of novel apocynin analogues. Eur J Med Chem 46: 2691-2698, 2011.
173. Lyle AN and Griendling KK. Modulation of vascular smooth muscle signaling by reactive oxygen species. Physiology (Bethesda) 21: 269-280, 2006.
174. Manea A. NADPH oxidase-derived reactive oxygen species: Involvement in vascular physiology and pathology. Cell Tissue Res 342: 325-339, 2010.
175. Marden JJ, Harraz MM, Williams AJ, Nelson K, Luo M, Paulson H, and Engelhardt JF. Redox modifier genes in amyotrophic lateral sclerosis in mice. J Clin Invest 117: 2913-2919, 2007.
176. Marengo JJ, Hidalgo C, and Bull R. Sulfhydryl oxidation modifies the calcium dependence of ryanodine-sensitive calcium channels of excitable cells. Biophys J 74: 1263-1277, 1998.
177. Martin-Villa JM, Corell A, Ramos-Amador JT, Ruiz-Contreras J, and Arnaiz-Villena A. Higher incidence of autoantibodies in X-linked chronic granulomatous disease carriers: Random X-chromosome inactivation may be related to autoimmunity. Autoimmunity 31: 261-264, 1999.
178. Martyn KD, Frederick LM, von Loehneysen K, Dinauer MC, and Knaus UG. Functional analysis of Nox4 reveals unique characteristics compared to other NADPH oxidases. Cell Signal 18: 69-82, 2006.
179. Massey V. Activation of molecular oxygen by flavins and flavoproteins. J Biol Chem 269: 22459-22462, 1994.
180. Matsue H, Edelbaum D, Shalhevet D, Mizumoto N, Yang C, Mummert ME, Oeda J, Masayasu H, and Takashima A. Generation and function of reactive oxygen species in dendritic cells during antigen presentation. J Immunol 171: 3010-3018, 2003.
181. Matthay MA and Zemans RL. The acute respiratory distress syndrome: Pathogenesis and treatment. Annu Rev Pathol 6: 147-163, 2011.
182. McCann SK, Dusting GJ, and Roulston CL. Early increase of Nox4 NADPH oxidase and superoxide generation following endothelin-1-induced stroke in conscious rats. J Neurosci Res 86: 2524-2534, 2008.
183. Mittal M, Gu XQ, Pak O, Pamenter ME, Haag D, Fuchs DB, Schermuly RT, Ghofrani HA, Brandes RP, Seeger W, Grimminger F, Haddad GG, and Weissmann N. Hypoxia induces Kv channel current inhibition by increased NADPH oxidase-derived reactive oxygen species. Free Radic Biol Med 52: 1033-1042, 2012.
184. Mittal M, Roth M, Konig P, Hofmann S, Dony E, Goyal P, Selbitz AC, Schermuly RT, Ghofrani HA, Kwapiszewska G, Kummer W, Klepetko W, Hoda MA, Fink L, Hanze J, Seeger W, Grimminger F, Schmidt HH, and Weissmann N. Hypoxia-dependent regulation of nonphagocytic NADPH oxidase subunit NOX4 in the pulmonary vasculature. Circ Res 101: 258-267, 2007.
185. Mizrahi A, Berdichevsky Y, Casey PJ, and Pick E. A Prenylated p47phox-p67phox-Rac1 chimera is a quintessential NADPH oxidase activator: Membrane association and functional capacity. J Biol Chem 285: 25485-25499, 2010.
186. Mofarrahi M, Brandes RP, Gorlach A, Hanze J, Terada LS, Quinn MT, Mayaki D, Petrof B, and Hussain SN. Regulation of proliferation of skeletal muscle precursor cells by NADPH oxidase. Antioxid Redox Signal 10: 559-574, 2008.
187. Mora-Pale M, Joon Kwon S, Linhardt RJ, and Dordick JS. Trimer hydroxylated quinone derived from apocynin targets cysteine residues of p47phox preventing the activation of human vascular NADPH oxidase. Free Radic Biol Med 52: 962-969, 2012.
188. Morand S, Ueyama T, Tsujibe S, Saito N, Korzeniowska A, and Leto TL. DUOX maturation factors form cell surface complexes with DUOX affecting the specificity of reactive oxygen species generation. FASEB J 23: 1205-1218, 2009.
189. Morris GM, Huey R, Lindstrom W, Sanner MF, Belew RK, Goodsell DS, and Olson AJ. AutoDock4 and autodocktools4: Automated docking with selective receptor flexibility. J Comput Chem 30: 2785-2791, 2009.
190. Mouri A, Nagai T, Ibi D, and Yamada K. Animal models of schizophrenia for molecular and pharmacological intervention and potential candidate molecules. Neurobiol Dis 53: 61-74, 2013.
191. Murillo MM, Carmona-Cuenca I, Del Castillo G, Ortiz C, Roncero C, Sanchez A, Fernandez M, and Fabregat I. Activation of NADPH oxidase by transforming growth factor-beta in hepatocytes mediates up-regulation of epidermal growth factor receptor ligands through a nuclear factor-kappaB-dependent mechanism. Biochem J 405: 251-259, 2007.
192. Nagaoka Y, Otsu K, Okada F, Sato K, Ohba Y, Kotani N, and Fujii J. Specific inactivation of cysteine protease-type cathepsin by singlet oxygen generated from naphthalene endoperoxides. Biochem Biophys Res Commun 331: 215-223, 2005.
193. Nakashima T, Iwashita T, Fujita T, Sato E, Niwano Y, Kohno M, Kuwahara S, Harada N, Takeshita S, and Oda T. A prodigiosin analogue inactivates NADPH oxidase in macrophage cells by inhibiting assembly of p47phox and Rac. J Biochem 143: 107-115, 2008.
194. Nauseef WM. How human neutrophils kill and degrade microbes: An integrated view. Immunol Rev 219: 88-102, 2007.
195. Nauseef WM. Nox enzymes in immune cells. Semin Immunopathol 30: 195-208, 2008.
196. Nauseef WM. Editorial: Nyet to NETs? A pause for healthy skepticism. J Leukoc Biol 91: 353-355, 2012.
197. Niethammer P, Grabher C, Look AT, and Mitchison TJ. A tissue-scale gradient of hydrogen peroxide mediates rapid wound detection in zebrafish. Nature 459: 996-999, 2009.
198. Nisbet RE, Graves AS, Kleinhenz DJ, Rupnow HL, Reed AL, Fan TH, Mitchell PO, Sutliff RL, and Hart CM. The role of NADPH oxidase in chronic intermittent hypoxiainduced pulmonary hypertension in mice. Am J Respir Cell Mol Biol 40: 601-609, 2009.
199. Nishida S, Yoshida LS, Shimoyama T, Nunoi H, Kobayashi T, and Tsunawaki S. Fungal metabolite gliotoxin targets flavocytochrome b558 in the activation of the human neutrophil NADPH oxidase. Infect Immun 73: 235-244, 2005.
200. Nose M, Accordini S, Artioli P, Barale F, Barbui C, Beneduce R, Berardi D, Bertolazzi G, Biancosino B, Bisogno A, Bivi R, Bogetto F, Boso M, Bozzani A, Bucolo P, Casale M, Cascone L, Ciammella L, Cicolini A, Cipresso G, Cipriani A, Colombo P, Dal Santo B, De Francesco M, Di Lorenzo G, Di Munzio W, Ducci G, Erlicher A, Esposito E, Ferrannini L, Ferrato F, Ferro A, Fragomeno N, Parise VF, Frova M, Gardellin F, Garzotto N, Giambartolomei A, Giupponi G, Grassi L, Grazian N, Grecu L, Guerrini G, Laddomada F, Lazzarin E, Lintas C, Malchiodi F, Malvini L, Marchiaro L, Marsilio A, Mauri MC, Mautone A, Menchetti M, Migliorini G, Mollica M, Moretti D, Mule S, Nicholau S, Nose F, Occhionero G, Pacilli AM, Pecchioli S, Percudani M, Piantato E, Piazza C, Pontarollo F, Pycha R, Quartesan R, Rillosi L, Risso F, Rizzo R, Rocca P, Roma S, Rossattini M, Rossi G, Sala A, Santilli C, Sarao G, Sarnicola A, Sartore F, Scarone S, Sciarma T, Siracusano A, Strizzolo S, Tansella M, Targa G, Tasser A, Tomasi R, Travaglini R, Veronese A, and Ziero S. Rationale and design of an independent randomised controlled trial evaluating the effectiveness of aripiprazole or haloperidol in combination with clozapine for treatment-resistant schizophrenia. Trials 10: 31, 2009.
201. O'Donnell BV, Tew DG, Jones OT, and England PJ. Studies on the inhibitory mechanism of iodonium compounds with special reference to neutrophil NADPH oxidase. Biochem J 290 (Pt 1): 41-49, 1993.
202. Ohnishi S and Takano K. Amyloid fibrils from the viewpoint of protein folding. Cell Mol Life Sci 61: 511-524, 2004.
203. Okros Z, Endreffy E, Novak Z, Maroti Z, Monostori P, Varga IS, Kiraly A, and Turi S. Changes in NADPH oxidase mRNA level can be detected in blood at inhaled corticosteroid treated asthmatic children. Life Sci 91: 907-911, 2012.
204. Olofsson P and Holmdahl R. Positional cloning of Ncf1-a piece in the puzzle of arthritis genetics. Scand J Immunol 58: 155-164, 2003.
205. Olsson LM, Lindqvist AK, Kallberg H, Padyukov L, Burkhardt H, Alfredsson L, Klareskog L, and Holmdahl R. A case-control study of rheumatoid arthritis identifies an associated single nucleotide polymorphism in the NCF4 gene, supporting a role for the NADPH-oxidase complex in autoimmunity. Arthritis Res Ther 9: R98, 2007.
206. Olsson LM, Nerstedt A, Lindqvist AK, Johansson SC, Medstrand P, Olofsson P, and Holmdahl R. Copy number variation of the gene NCF1 is associated with rheumatoid arthritis. Antioxid Redox Signal 16: 71-78, 2011.
207. Orrell RW. Motor neuron disease: Systematic reviews of treatment for ALS and SMA. Br Med Bull 93: 145-159, 2010.
208. Pandey R, Chander R, and Sainis KB. Prodigiosins: A novel family of immunosuppressants with anti-cancer activity. Indian J Biochem Biophys 44: 295-302, 2007.
209. Park L, Anrather J, Zhou P, Frys K, Pitstick R, Younkin S, Carlson GA, and Iadecola C. NADPH-oxidase-derived reactive oxygen species mediate the cerebrovascular dysfunction induced by the amyloid beta peptide. J Neurosci 25: 1769-1777, 2005.
210. Park L, Zhou P, Pitstick R, Capone C, Anrather J, Norris EH, Younkin L, Younkin S, Carlson G, McEwen BS, and Iadecola C. Nox2-derived radicals contribute to neurovascular and behavioral dysfunction in mice overexpressing the amyloid precursor protein. Proc Natl Acad Sci USA 105: 1347-1352, 2008.
211. Parker H and Winterbourn CC. Reactive oxidants and myeloperoxidase and their involvement in neutrophil extracellular traps. Front Immunol 3: 424, 2012.
212. Parkos CA, Dinauer MC, Walker LE, Rodger AA, Jesaitis AJ, and Orkin SH. Primary structure and unique expression of the 22-kilodalton light chain of human neutrophil cytochrome. Proc Natl Acad Sci USA 85: 3319-3323, 1988.
213. Pastukh VM, Zhang L, Ruchko MV, Gorodnya O, Bardwell GC, Tuder RM, and Gillespie MN. Oxidative DNA damage in lung tissue from patients with COPD is clustered in functionally significant sequences. Int J Chron Obstruct Pulmon Dis 6: 209-217, 2011.
214. Pawate S, Shen Q, Fan F, and Bhat NR. Redox regulation of glial inflammatory response to lipopolysaccharide and interferongamma. J Neurosci Res 77: 540-551, 2004.
215. Pearse DB and Dodd JM. Ischemia-reperfusion lung injury is prevented by apocynin, a novel inhibitor of leukocyte NADPH oxidase. Chest 116: 55S-56S, 1999.
216. Pendyala S, Gorshkova IA, Usatyuk PV, He D, Pennathur A, Lambeth JD, Thannickal VJ, and Natarajan V. Role of Nox4 and Nox2 in hyperoxia-induced reactive oxygen species generation and migration of human lung endothelial cells. Antioxid Redox Signal 11: 747-764, 2009.
217. Pendyala S and Natarajan V. Redox regulation of Nox proteins. Respir Physiol Neurobiol 174: 265-271, 2010.
218. Perry BN, Govindarajan B, Bhandarkar SS, Knaus UG, Valo M, Sturk C, Carrillo CO, Sohn A, Cerimele F, Dumont D, Losken A, Williams J, Brown LF, Tan X, Ioffe E, Yancopoulos GD, and Arbiser JL. Pharmacologic blockade of angiopoietin-2 is efficacious against model hemangiomas in mice. J Invest Dermatol 126: 2316-2322, 2006.
219. Peters EA, Hiltermann JTN, and Stolk J. Effect of apocynin on ozone-induced airway hyperresponsiveness to methacholine in asthmatics. Free Radic Biol Med 31: 1442-1447, 2001.
220. Peterson JR, Burmeister MA, Tian X, Zhou Y, Guruju MR, Stupinski JA, Sharma RV, and Davisson RL. Genetic silencing of Nox2 and Nox4 reveals differential roles of these NADPH oxidase homologues in the vasopressor and dipsogenic effects of brain angiotensin II. Hypertension 54: 1106-1114, 2009.
221. Petry A, Djordjevic T, Weitnauer M, Kietzmann T, Hess J, and Gorlach A. NOX2 and NOX4 mediate proliferative response in endothelial cells. Antioxid Redox Signal 8: 1473-1484, 2006.
222. Poewe W, Mahlknecht P, and Jankovic J. Emerging therapies for Parkinson's disease. Curr Opin Neurol 25: 448-459, 2012.
223. Pollock JD, Williams DA, Gifford MA, Li LL, Du X, Fisherman J, Orkin SH, Doerschuk CM, and Dinauer MC. Mouse model of X-linked chronic granulomatous disease, an inherited defect in phagocyte superoxide production. Nat Genet 9: 202-209, 1995.
224. Pongnimitprasert N, El-Benna J, Foglietti MJ, Gougerot-Pocidalo MA, Bernard M, and Braut-Boucher F. Potential role of the "NADPH oxidases" (NOX/DUOX) family in cystic fibrosis. Ann Biol Clin (Paris) 66: 621-629, 2008.
225. Pourova J, Kottova M, Voprsalova M, and Pour M. Reactive oxygen and nitrogen species in normal physiological processes. Acta Physiol (Oxf) 198: 15-35, 2010.
226. Pratt AJ, Getzoff ED, and Perry JJ. Amyotrophic lateral sclerosis: Update and new developments. Degener Neurol Neuromuscul Dis 2012: 1-14, 2012.
227. Priller C, Bauer T, Mitteregger G, Krebs B, Kretzschmar HA, and Herms J. Synapse formation and function is modulated by the amyloid precursor protein. J Neurosci 26: 7212-7221, 2006.
228. Profita M, Sala A, Bonanno A, Riccobono L, Ferraro M, La Grutta S, Albano GD, Montalbano AM, and Gjomarkaj M. Chronic obstructive pulmonary disease and neutrophil infiltration: Role of cigarette smoke and cyclooxygenase products. Am J Physiol Lung Cell Mol Physiol 298: L261-L269, 2010.
229. Prokopowicz ZM, Arce F, Biedron R, Chiang CL, Ciszek M, Katz DR, Nowakowska M, Zapotoczny S, Marcinkiewicz J, and Chain BM. Hypochlorous acid: A natural adjuvant that facilitates antigen processing, cross-priming, and the induction of adaptive immunity. J Immunol 184: 824-835, 2010.
230. Prosser BL, Khairallah RJ, Ziman AP, Ward CW, and Lederer WJ. X-ROS signaling in the heart and skeletal muscle: Stretch-dependent local ROS regulates [Ca(2 + )](i). J Mol Cell Cardiol 58: 172-181, 2013.
231. Prosser BL, Ward CW, and Lederer WJ. X-ROS signaling: Rapid mechano-chemo transduction in heart. Science 333: 1440-1445, 2011.
232. Quinn MT, Ammons MC, and Deleo FR. The expanding role of NADPH oxidases in health and disease: No longer just agents of death and destruction. Clin Sci (Lond) 111: 1-20, 2006.
233. Raffa M, Atig F, Mhalla A, Kerkeni A, and Mechri A. Decreased glutathione levels and impaired antioxidant enzyme activities in drug-naive first-episode schizophrenic patients. BMC Psychiatry 11: 124, 2011.
234. Rahman FZ, Hayee B, Chee R, Segal AW, and Smith AM. Impaired macrophage function following bacterial stimulation in chronic granulomatous disease. Immunology 128: 253-259, 2009.
235. Repine JE, Clawson CC, White JG, and Holmes B. Spectrum of function of neutrophils from carriers of sex-linked chronic granulomatous disease. J Pediatr 87: 901-907, 1975.
236. Reynolds WF, Sermet-Gaudelus I, Gausson V, Feuillet MN, Bonnefont JP, Lenoir G, Descamps-Latscha B, and Witko-Sarsat V. Myeloperoxidase promoter polymorphism-463G is associated with more severe clinical expression of cystic fibrosis pulmonary disease. Mediators Inflamm 2006: 36735, 2006.
237. Rhee SG, Chang TS, Bae YS, Lee SR, and Kang SW. Cellular regulation by hydrogen peroxide. J Am Soc Nephrol 14: S211-S215, 2003.
238. Riboldi G, Nizzardo M, Simone C, Falcone M, Bresolin N, Comi GP, and Corti S. ALS genetic modifiers that increase survival of SOD1 mice and are suitable for therapeutic development. Prog Neurobiol 95: 133-148, 2011.
239. Roberts RL, Hollis-Moffatt JE, Gearry RB, Kennedy MA, Barclay ML, and Merriman TR. Confirmation of association of IRGM and NCF4 with ileal Crohn's disease in a population-based cohort. Genes Immun 9: 561-565, 2008.
240. Romani L, Fallarino F, De Luca A, Montagnoli C, D'Angelo C, Zelante T, Vacca C, Bistoni F, Fioretti MC, Grohmann U, Segal BH, and Puccetti P. Defective tryptophan catabolism underlies inflammation in mouse chronic granulomatous disease. Nature 451: 211-215, 2008.
241. Rossler W, Salize HJ, van Os J, and Riecher-Rossler A. Size of burden of schizophrenia and psychotic disorders. Eur Neuropsychopharmacol 15: 399-409, 2005.
242. Roussin A, Le Cabec V, Lonchampt M, De Nadai J, Canet E, and Maridonneau-Parini I. Neutrophil-associated inflammatory responses in rats are inhibited by phenylarsine oxide. Eur J Pharmacol 322: 91-96, 1997.
243. Royer-Pokora B, Kunkel LM, Monaco AP, Goff SC, Newburger PE, Baehner RL, Cole FS, Curnutte JT, and Orkin SH. Cloning the gene for an inherited human disorder-chronic granulomatous disease-on the basis of its chromosomal location. Nature 322: 32-38, 1986.
244. Rubenfeld GD, Caldwell E, Peabody E, Weaver J, Martin DP, Neff M, Stern EJ, and Hudson LD. Incidence and outcomes of acute lung injury. N Engl J Med 353: 1685-1693, 2005.
245. Ruiz-Litago F, Seco J, Echevarria E, Martinez-Cengotitabengoa M, Gil J, Irazusta J, and Gonzalez-Pinto AM. Adaptive response in the antioxidant defence system in the course and outcome in first-episode schizophrenia patients: A 12-months follow-up study. Psychiatry Res 200: 218-222, 2012.
246. Ruparelia P, Szczepura KR, Summers C, Solanki CK, Balan K, Newbold P, Bilton D, Peters AM, and Chilvers ER. Quantification of neutrophil migration into the lungs of patients with chronic obstructive pulmonary disease. Eur J Nucl Med Mol Imaging 38: 911-919, 2011.
247. Rybicka JM, Balce DR, Chaudhuri S, Allan ER, and Yates RM. Phagosomal proteolysis in dendritic cells is modulated by NADPH oxidase in a pH-independent manner. EMBO J 31: 932-944, 2012.
248. Rybicka JM, Balce DR, Khan MF, Krohn RM, and Yates RM. NADPH oxidase activity controls phagosomal proteolysis in macrophages through modulation of the lumenal redox environment of phagosomes. Proc Natl Acad Sci USA 107: 10496-10501, 2010.
249. Salguero G, Akin E, Templin C, Kotlarz D, Doerries C, Landmesser U, Grote K, and Schieffer B. Renovascular hypertension by two-kidney one-clip enhances endothelial progenitor cell mobilization in a p47phox-dependent manner. J Hypertens 26: 257-268, 2008.
250. Salmeen A and Barford D. Functions and mechanisms of redox regulation of cysteine-based phosphatases. Antioxid Redox Signal 7: 560-577, 2005.
251. Sanchez G, Pedrozo Z, Domenech RJ, Hidalgo C, and Donoso P. Tachycardia increases NADPH oxidase activity and RyR2 S-glutathionylation in ventricular muscle. J Mol Cell Cardiol 39: 982-991, 2005.
252. Sancho P and Fabregat I. The NADPH oxidase inhibitor VAS2870 impairs cell growth and enhances TGF-b-induced apoptosis of liver tumor cells. Biochem Pharmacol 81: 917-924, 2011.
253. Sareila O, Kelkka T, Pizzolla A, Hultqvist M, and Holmdahl R. NOX2 complex-derived ROS as immune regulators. Antioxid Redox Signal 15: 2197-2208, 2010.
254. Sauaia A, Moore FA, Moore EE, Moser KS, Brennan R, Read RA, and Pons PT. Epidemiology of trauma deaths: A reassessment. J Trauma 38: 185-193, 1995.
255. Sautin YY, Nakagawa T, Zharikov S, and Johnson RJ. Adverse effects of the classic antioxidant uric acid in adipocytes: NADPH oxidase-mediated oxidative/nitrosative stress. Am J Physiol Cell Physiol 293: C584-C596, 2007.
256. Savina A, Jancic C, Hugues S, Guermonprez P, Vargas P, Moura IC, Lennon-Dumenil AM, Seabra MC, Raposo G, and Amigorena S. NOX2 controls phagosomal pH to regulate antigen processing during crosspresentation by dendritic cells. Cell 126: 205-218, 2006.
257. Schewe T. Molecular actions of ebselen-an antiinflammatory antioxidant. Gen Pharmacol 26: 1153-1169, 1995.
258. Schiavone S, Sorce S, Dubois-Dauphin M, Jaquet V, Colaianna M, Zotti M, Cuomo V, Trabace L, and Krause KH. Involvement of NOX2 in the development of behavioral and pathologic alterations in isolated rats. Biol Psychiatry 66: 384-392, 2009.
259. Schneider SD, Rusconi S, Seger RA, and Hossle JP. Adenovirus-mediated gene transfer into monocyte-derived macrophages of patients with X-linked chronic granulomatous disease: Ex vivo correction of deficient respiratory burst. Gene Ther 4: 524-532, 1997.
260. Schroder K. Isoform specific functions of Nox proteinderived reactive oxygen species in the vasculature. Curr Opin Pharmacol 10: 122-126, 2010.
261. Schroder K, Schutz S, Schloffel I, Batz S, Takac I, Weissmann N, Michaelis UR, Koyanagi M, and Brandes RP. Hepatocyte growth factor induces a proangiogenic phenotype and mobilizes endothelial progenitor cells by activating Nox2. Antioxid Redox Signal 15: 915-923, 2011.
262. Sedeek M, Callera G, Montezano A, Gutsol A, Heitz F, Szyndralewiez C, Page P, Kennedy CR, Burns KD, Touyz RM, and Hebert RL. Critical role of Nox4-based NADPH oxidase in glucose-induced oxidative stress in the kidney: Implications in type 2 diabetic nephropathy. Am J Physiol Renal Physiol 299: F1348-F1358, 2010.
263. Sedeek M, Gutsol A, Montezano AC, Burger D, Nguyen Dinh Cat A, Kennedy CRJ, Burns KD, Cooper ME, Jandeleit-Dahm K, Page P, Szyndralewiez C, Heitz F, Hebert RL, and Touyz RM. Renoprotective effects of a novel Nox1/4 inhibitor in a mouse model of Type 2 diabetes. Clin Sci 124: 191-202, 2013.
264. Sedeek M, Hebert RL, Kennedy CR, Burns KD, and Touyz RM. Molecular mechanisms of hypertension: Role of Nox family NADPH oxidases. Curr Opin Nephrol Hypertens 18: 122-127, 2009.
265. Segal AW. How neutrophils kill microbes. Annu Rev Immunol 23: 197-223, 2005.
266. Segal BH, Veys P, Malech H, and Cowan MJ. Chronic granulomatous disease: Lessons from a rare disorder. Biol Blood Marrow Transplant 17: S123-S131, 2011.
267. Selkoe DJ. Alzheimer's disease. Cold Spring Harb Perspect Biol 3: Pii: A004457, 2011.
268. Shao L, Li H, Pazhanisamy SK, Meng A, Wang Y, and Zhou D. Reactive oxygen species and hematopoietic stem cell senescence. Int J Hematol 94: 24-32, 2011.
269. Sheu ML, Chiang CK, Tsai KS, Ho FM, Weng TI, Wu HY, and Liu SH. Inhibition of NADPH oxidase-related oxidative stress-triggered signaling by honokiol suppresses high glucose-induced human endothelial cell apoptosis. Free Radic Biol Med 44: 2043-2050, 2008.
270. Shimohama S, Tanino H, Kawakami N, Okamura N, Kodama H, Yamaguchi T, Hayakawa T, Nunomura A, Chiba S, Perry G, Smith MA, and Fujimoto S. Activation of NADPH oxidase in Alzheimer's disease brains. Biochem Biophys Res Commun 273: 5-9, 2000.
271. Siddiqui S, Anderson VL, Hilligoss DM, Abinun M, Kuijpers TW, Masur H, Witebsky FG, Shea YR, Gallin JI, Malech HL, and Holland SM. Fulminant mulch pneumonitis: An emergency presentation of chronic granulomatous disease. Clin Infect Dis 45: 673-681, 2007.
272. Sies H. Ebselen, a selenoorganic compound as glutathione peroxidase mimic. Free Radic Biol Med 14: 313-323, 1993.
273. Simonneau G, Robbins IM, Beghetti M, Channick RN, Delcroix M, Denton CP, Elliott CG, Gaine SP, Gladwin MT, Jing ZC, Krowka MJ, Langleben D, Nakanishi N, and Souza R. Updated clinical classification of pulmonary hypertension. J Am Coll Cardiol 54: S43-S54, 2009.
274. Simons JM, Hart BA, Ip Vai Ching TR, Van Dijk H, and Labadie RP. Metabolic activation of natural phenols into selective oxidative burst agonists by activated human neutrophils. Free Radic Biol Med 8: 251-258, 1990.
275. Sleasman JW. The association between immunodeficiency and the development of autoimmune disease. Adv Dent Res 10: 57-61, 1996.
276. Smith SM, Min J, Ganesh T, Diebold B, Kawahara T, Zhu Y, McCoy J, Sun A, Snyder JP, Fu H, Du Y, Lewis I, and Lambeth JD. Ebselen and congeners inhibit NADPH oxidase 2-dependent superoxide generation by interrupting the binding of regulatory subunits. Chem Biol 19: 752-763, 2012.
277. Smith Y, Wichmann T, Factor SA, and DeLong MR. Parkinson's disease therapeutics: New developments and challenges since the introduction of levodopa. Neuropsychopharmacology 37: 213-246, 2012.
278. Soehnlein O and Lindbom L. Phagocyte partnership during the onset and resolution of inflammation. Nat Rev Immunol 10: 427-439, 2010.
279. Song SX, Gao JL, Wang KJ, Li R, Tian YX, Wei JQ, and Cui JZ. Attenuation of brain edema and spatial learning de fi cits by the inhibition of NADPH oxidase activity using apocynin following diffuse traumatic brain injury in rats. Mol Med Report 7: 327-331, 2013.
280. Sorce S, Schiavone S, Tucci P, Colaianna M, Jaquet V, Cuomo V, Dubois-Dauphin M, Trabace L, and Krause KH. The NADPH oxidase NOX2 controls glutamate release: A novel mechanism involved in psychosis-like ketamine responses. J Neurosci 30: 11317-11325, 2010.
281. Stasia MJ, Mollin M, Martel C, Satre V, Coutton C, Amblard F, Vieville G, van Montfrans JM, Boelens JJ, Veenstra-Knol HE, van Leeuwen K, de Boer M, Brion JP, and Roos D. Functional and genetic characterization of two extremely rare cases of Williams-Beuren syndrome associated with chronic granulomatous disease. Eur J Hum Genet 21: 1079-1084, 2013.
282. Stefanska J and Pawliczak R. Apocynin: Molecular aptitudes. Mediators Inflamm 2008: 106507, 2008.
283. Stefanska J, Sarniak A, Wlodarczyk A, Sokolowska M, Doniec Z, Bialasiewicz P, Nowak D, and Pawliczak R. Hydrogen peroxide and nitrite reduction in exhaled breath condensate of COPD patients. Pulm Pharmacol Ther 25: 343-348, 2012.
284. Stefanska J, Sarniak A, Wlodarczyk A, Sokolowska M, Pniewska E, Doniec Z, Nowak D, and Pawliczak R. Apocynin reduces reactive oxygen species concentrations in exhaled breath condensate in asthmatics. Exp Lung Res 38: 90-99, 2012.
285. Stielow C, Catar RA, Muller G, Wingler K, Scheurer P, Schmidt HH, and Morawietz H. Novel Nox inhibitor of oxLDL-induced reactive oxygen species formation in human endothelial cells. Biochem Biophys Res Commun 344: 200-205, 2006.
286. Stolk J, Hiltermann T, Dijkman J, and Verhoeven A. Characteristics of the inhibition of NADPH oxidase activation in neutrophils by apocynin, a methoxy-substituted catechol. Am J Respir Cell Mol Biol 11: 95, 1994.
287. Sumimoto H. Structure, regulation and evolution of Noxfamily NADPH oxidases that produce reactive oxygen species. FEBS J 275: 3249-3277, 2008.
288. Sumimoto H, Kage Y, Nunoi H, Sasaki H, Nose T, Fukumaki Y, Ohno M, Minakami S, and Takeshige K. Role of Sr. homology 3 domains in assembly and activation of the phagocyte NADPH oxidase. Proc Natl Acad Sci USA 91: 5345-5349, 1994.
289. Sun QA, Hess DT, Nogueira L, Yong S, Bowles DE, Eu J, Laurita KR, Meissner G, and Stamler JS. Oxygen-coupled redox regulation of the skeletal muscle ryanodine receptor-Ca2 + release channel by NADPH oxidase 4. Proc Natl Acad Sci USA 108: 16098-16103, 2011.
290. Sun QA, Hess DT, Wang B, Miyagi M, and Stamler JS. Off-target thiol alkylation by the NADPH oxidase inhibitor 3-benzyl-7-(2-benzoxazolyl)thio-1,2,3-triazolo[4,5-d] pyrimidine (VAS2870). Free Radic Biol Med 52: 1897-1902, 2012.
291. Sundaresan M, Yu ZX, Ferrans VJ, Irani K, and Finkel T. Requirement for generation of H2O2 for platelet-derived growth factor signal transduction. Science 270: 296-299, 1995.
292. Surace MJ and Block ML. Targeting microglia-mediated neurotoxicity: The potential of NOX2 inhibitors. Cell Mol Life Sci 69: 2409-2427, 2012.
293. Sutcliffe A, Hollins F, Gomez E, Saunders R, Doe C, Cooke M, Challiss RA, and Brightling CE. Increased nicotinamide adenine dinucleotide phosphate oxidase 4 expression mediates intrinsic airway smooth muscle hypercontractility in asthma. Am J Respir Crit Care Med 185: 267-274, 2012.
294. Takac I, Schroder K, Zhang L, Lardy B, Anilkumar N, Lambeth JD, Shah AM, Morel F, and Brandes RP. The E-loop is involved in hydrogen peroxide formation by the NADPH oxidase Nox4. J Biol Chem 286: 13304-13313, 2011.
295. Tang XN, Cairns B, Cairns N, and Yenari MA. Apocynin improves outcome in experimental stroke with a narrow dose range. Neuroscience 154: 556-562, 2008.
296. Tang XN, Cairns B, Kim JY, and Yenari MA. NADPH oxidase in stroke and cerebrovascular disease. Neurol Res 34: 338-345, 2012.
297. Tang XN, Zheng Z, Giffard RG, and Yenari MA. Significance of marrow-derived nicotinamide adenine dinucleotide phosphate oxidase in experimental ischemic stroke. Ann Neurol 70: 606-615, 2011.
298. Tasaka S, Amaya F, Hashimoto S, and Ishizaka A. Roles of oxidants and redox signaling in the pathogenesis of acute respiratory distress syndrome. Antioxid Redox Signal 10: 739-753, 2008.
299. Taur Y and Frishman WH. The cardiac ryanodine receptor (RyR2) and its role in heart disease. Cardiol Rev 13: 142-146, 2005.
300. Teahan C, Rowe P, Parker P, Totty N, and Segal AW. The X-linked chronic granulomatous disease gene codes for the b-chain of cytochrome b-245. Nature 327: 720-721, 1987.
301. ten Freyhaus H, Huntgeburth M, Wingler K, Schnitker J, Baumer AT, Vantler M, Bekhite MM, Wartenberg M, Sauer H, and Rosenkranz S. Novel Nox inhibitor VAS2870 attenuates PDGF-dependent smooth muscle cell chemotaxis, but not proliferation. Cardiovasc Res 71: 331-341, 2006.
302. Teng RJ, Du J, Welak S, Guan T, Eis A, Shi Y, and Konduri GG. Cross talk between NADPH oxidase and autophagy in pulmonary artery endothelial cells with intrauterine persistent pulmonary hypertension. Am J Physiol Lung Cell Mol Physiol 302: L651-L663, 2012.
303. Tian N, Moore RS, Phillips WE, Lin L, Braddy S, Pryor JS, Stockstill RL, Hughson MD, and Manning RD, Jr. NADPH oxidase contributes to renal damage and dysfunction in Dahl salt-sensitive hypertension. Am J Physiol Regul Integr Comp Physiol 295: R1858-R1865, 2008.
304. Touyz RM, Chen X, Tabet F, Yao G, He G, Quinn MT, Pagano PJ, and Schiffrin EL. Expression of a functionally active gp91phox-containing neutrophil-type NAD(P)H oxidase in smooth muscle cells from human resistance arteries: Regulation by angiotensin II. Circ Res 90: 1205-1213, 2002.
305. Touyz RM, Mercure C, He Y, Javeshghani D, Yao G, Callera GE, Yogi A, Lochard N, and Reudelhuber TL. Angiotensin II-dependent chronic hypertension and cardiac hypertrophy are unaffected by gp91phox-containing NADPH oxidase. Hypertension 45: 530-537, 2005.
306. Trumbull KA, McAllister D, Gandelman MM, Fung WY, Lew T, Brennan L, Lopez N, Morre J, Kalyanaraman B, and Beckman JS. Diapocynin and apocynin administration fails to significantly extend survival in G93A SOD1 ALS mice. Neurobiol Dis 45: 137-144, 2012.
307. Tsai SK, Huang SS, and Hong CY. Myocardial protective effect of honokiol: An active component in Magnolia officinalis. Planta Med 62: 503-506, 1996.
308. Ueno N, Takeya R, Miyano K, Kikuchi H, and Sumimoto H. The NADPH oxidase Nox3 constitutively produces superoxide in a p22phox-dependent manner: Its regulation by oxidase organizers and activators. J Biol Chem 280: 23328-23339, 2005.
309. Ullevig S, Zhao Q, Lee CF, Seok Kim H, Zamora D, and Asmis R. NADPH oxidase 4 mediates monocyte priming and accelerated chemotaxis induced by metabolic stress. Arterioscler Thromb Vasc Biol 32: 415-426, 2012.
310. Ungvari Z, Csiszar A, Edwards JG, Kaminski PM, Wolin MS, Kaley G, and Koller A. Increased superoxide production in coronary arteries in hyperhomocysteinemia role of tumor necrosis factor-a, NAD (P) H oxidase, and inducible nitric oxide synthase. Arterioscler Thromb Vasc Biol 23: 418-424, 2003.
311. Urao N, McKinney RD, Fukai T, and Ushio-Fukai M. NADPH oxidase 2 regulates bone marrow microenvironment following hindlimb ischemia: Role in reparative mobilization of progenitor cells. Stem Cells 30: 923-934, 2012.
312. Veal EA, Day AM, and Morgan BA. Hydrogen peroxide sensing and signaling. Mol Cell 26: 1-14, 2007.
313. Vingsbo-Lundberg C, Nordquist N, Olofsson P, Sundvall M, Saxne T, Pettersson U, and Holmdahl R. Genetic control of arthritis onset, severity and chronicity in a model for rheumatoid arthritis in rats. Nat Genet 20: 401-404, 1998.
314. Violi F, Sanguigni V, Carnevale R, Plebani A, Rossi P, Finocchi A, Pignata C, De Mattia D, Martire B, Pietrogrande MC, Martino S, Gambineri E, Soresina AR, Pignatelli P, Martino F, Basili S, and Loffredo L. Hereditary deficiency of gp91(phox) is associated with enhanced arterial dilatation: Results of a multicenter study. Circulation 120: 1616-1622, 2009.
315. Vlahos R, Stambas J, Bozinovski S, Broughton BR, Drummond GR, and Selemidis S. Inhibition of Nox2 oxidase activity ameliorates influenza A virus-induced lung inflammation. PLoS Pathog 7: E1001271, 2011.
316. Vlahos R, Stambas J, and Selemidis S. Suppressing production of reactive oxygen species (ROS) for influenza A virus therapy. Trends Pharmacol Sci 33: 3-8, 2012.
317. Volpp BD, Nauseef WM, Donelson JE, Moser DR, and Clark RA. Cloning of the cDNA and functional expression of the 47-kilodalton cytosolic component of human neutrophil respiratory burst oxidase. Proc Natl Acad Sci USA 86: 7195-7199, 1989.
318. Wallace DC. Mitochondrial diseases in man and mouse. Science 283: 1482-1488, 1999.
319. Wang JP, Hsu EF, Raung SL, Chang LC, Tsao LT, Lin PL, and Chen CC. Inhibition by magnolol of formylmethionyl-leucyl-phenyl alanine-induced respiratory burst in rat neutrophils. J Pharm Pharmacol 51: 285-294, 1999.
320. Wang Y and Lou MF. The regulation of NADPH oxidase and its association with cell proliferation in human lens epithelial cells. Invest Ophthalmol Vis Sci 50: 2291-2300, 2009.
321. Wang Y, Rosen H, Madtes DK, Shao B, Martin TR, Heinecke JW, and Fu X. Myeloperoxidase inactivates TIMP-1 by oxidizing its N-terminal cysteine residue: An oxidative mechanism for regulating proteolysis during inflammation. J Biol Chem 282: 31826-31834, 2007.
322. Watt AP, Schock BC, and Ennis M. Neutrophils and eosinophils: Clinical implications of their appearance, presence and disappearance in asthma and COPD. Curr Drug Targets Inflamm Allergy 4: 415-423, 2005.
323. Weyker PD, Webb CA, Kiamanesh D, and Flynn BC. Lung ischemia reperfusion injury: A bench-to-bedside review. Semin Cardiothorac Vasc Anesth 17: 28-43, 2013.
324. Wientjes FB, Hsuan JJ, Totty NF, and Segal AW. p40phox, a third cytosolic component of the activation complex of the NADPH oxidase to contain src homology 3 domains. Biochem J 296 (Pt 3): 557-561, 1993.
325. Wilkinson BL and Landreth GE. The microglial NADPH oxidase complex as a source of oxidative stress in Alzheimer's disease. J Neuroinflammation 3: 30, 2006.
326. Wingler K, Altenhoefer S, Kleikers PM, Radermacher K, Kleinschnitz C, and Schmidt HHW. VAS2870 is a pan-NADPH oxidase inhibitor. Cell Mol Life Sci 69: 3159-3160, 2012.
327. Winterbourn CC. Reconciling the chemistry and biology of reactive oxygen species. Nat Chem Biol 4: 278-286, 2008.
328. Winterbourn CC and Hampton MB. Thiol chemistry and specificity in redox signaling. Free Radic Biol Med 45: 549-561, 2008.
329. Witko-Sarsat V, Allen RC, Paulais M, Nguyen AT, Bessou G, Lenoir G, and Descamps-Latscha B. Disturbed myeloperoxidase-dependent activity of neutrophils in cystic fibrosis homozygotes and heterozygotes, and its correction by amiloride. J Immunol 157: 2728-2735, 1996.
330. Wu DC, Re DB, Nagai M, Ischiropoulos H, and Przedborski S. The inflammatory NADPH oxidase enzyme modulates motor neuron degeneration in amyotrophic lateral sclerosis mice. Proc Natl Acad Sci USA 103: 12132-12137, 2006.
331. Wu DC, Teismann P, Tieu K, Vila M, Jackson-Lewis V, Ischiropoulos H, and Przedborski S. NADPH oxidase mediates oxidative stress in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine model of Parkinson's disease. Proc Natl Acad Sci USA 100: 6145-6150, 2003.
332. Yamamoto E, Tamamaki N, Nakamura T, Kataoka K, Tokutomi Y, Dong YF, Fukuda M, Matsuba S, Ogawa H, and Kim-Mitsuyama S. Excess salt causes cerebral neuronal apoptosis and inflammation in stroke-prone hypertensive rats through angiotensin II-induced NADPH oxidase activation. Stroke 39: 3049-3056, 2008.
333. Yang Z, Sharma AK, Marshall M, Kron IL, and Laubach VE. NADPH oxidase in bone marrow-derived cells mediates pulmonary ischemia-reperfusion injury. Am J Respir Cell Mol Biol 40: 375-381, 2009.
334. Yao H, Edirisinghe I, Yang SR, Rajendrasozhan S, Kode A, Caito S, Adenuga D, and Rahman I. Genetic ablation of NADPH oxidase enhances susceptibility to cigarette smoke-induced lung inflammation and emphysema in mice. Am J Pathol 172: 1222-1237, 2008.
335. Yoshida LS, Abe S, and Tsunawaki S. Fungal gliotoxin targets the onset of superoxide-generating NADPH oxidase of human neutrophils. Biochem Biophys Res Commun 268: 716-723, 2000.
336. Yu B, Chen Y, Wu Q, Li P, Shao Y, Zhang J, Zhong Q, Peng X, Yang H, Hu X, Chen B, Guan M, Wan J, and Zhang W. The association between single-nucleotide polymorphisms of NCF2 and systemic lupus erythematosus in Chinese mainland population. Clin Rheumatol 30: 521-527, 2010.
337. Yuan H, Zhang X, Huang X, Lu Y, Tang W, Man Y, Wang S, Xi J, and Li J. NADPH oxidase 2-derived reactive oxygen species mediate FFAs-induced dysfunction and apoptosis of beta-cells via JNK, p38 MAPK and p53 pathways. PLoS One 5: E15726, 2010.
338. Zhang M, Nomura A, Uchida Y, Iijima H, Sakamoto T, Iishii Y, Morishima Y, Mochizuki M, Masuyama K, Hirano K, and Sekizawa K. Ebselen suppresses late airway responses and airway inflammation in guinea pigs. Free Radic Biol Med 32: 454-464, 2002.
339. Zhang QG, Laird MD, Han D, Nguyen K, Scott E, Dong Y, Dhandapani KM, and Brann DW. Critical role of NADPH oxidase in neuronal oxidative damage and microglia activation following traumatic brain injury. PLoS One 7: E34504, 2012.
340. Zhang WJ, Wei H, Tien YT, and Frei B. Genetic ablation of phagocytic NADPH oxidase in mice limits TNFalphainduced inflammation in the lungs but not other tissues. Free Radic Biol Med 50: 1517-1525, 2011.
341. Zhao H, Mayhan WG, Arrick DM, Xiong W, and Sun H. Alcohol-induced exacerbation of ischemic brain injury: Role of NAD(P)H oxidase. Alcohol Clin Exp Res 34: 1948-1955, 2010.
342. Zimmerman MC, Dunlay RP, Lazartigues E, Zhang Y, Sharma RV, Engelhardt JF, and Davisson RL. Requirement for Rac1-dependent NADPH oxidase in the cardiovascular and dipsogenic actions of angiotensin II in the brain. Circ Res 95: 532-539, 2004.